PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-7022
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab ; volume:4 ; number:1 ; day:28 ; month:2 ; year:2014 ; pages:1 ; date:3.2014
Clinical and translational allergy ; 4, Heft 1 (28.2.2014), 1, 3.2014
- Creator
-
Vilella, Mireia
Bosque, Montserrat
Trujillo, Juan
Domingo, Xavier
Guijarro, Elisabet
Asensio, Òscar
Valdesoiro, Laura
Larramona, Helena
Maestro, Alba
Domingo, Christian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/2045-7022-4-S1-P49
- URN
-
urn:nbn:de:101:1-2021080821114195210379
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vilella, Mireia
- Bosque, Montserrat
- Trujillo, Juan
- Domingo, Xavier
- Guijarro, Elisabet
- Asensio, Òscar
- Valdesoiro, Laura
- Larramona, Helena
- Maestro, Alba
- Domingo, Christian
- SpringerLink (Online service)
Other Objects (12)
Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Exhaled and nasal nitric oxide in laryngectomized patients
Reference values for exhaled nitric oxide (reveno) study
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Exhaled nitric oxide decreases after positive food-allergen challenge
Levels of Exhaled Breath Condensate pH and Fractional Exhaled Nitric Oxide in Retired Coal Miners
Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
Factors affecting exhaled nitric oxide measurements: the effect of sex
Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Exhaled and nasal nitric oxide in laryngectomized patients
Reference values for exhaled nitric oxide (reveno) study
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Exhaled nitric oxide decreases after positive food-allergen challenge
Levels of Exhaled Breath Condensate pH and Fractional Exhaled Nitric Oxide in Retired Coal Miners
Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
Factors affecting exhaled nitric oxide measurements: the effect of sex
Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Exhaled and nasal nitric oxide in laryngectomized patients
Reference values for exhaled nitric oxide (reveno) study
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in children with severe allergic disease: a case series
Exhaled nitric oxide decreases after positive food-allergen challenge
Levels of Exhaled Breath Condensate pH and Fractional Exhaled Nitric Oxide in Retired Coal Miners
Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
Factors affecting exhaled nitric oxide measurements: the effect of sex
Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics